Industry consultant Michael Drues will discuss how medical device companies can better prepare for FDA inspections.
WASHINGTON — Federal regulators responsible for the safety of the U.S. drug supply are still struggling to get back to where they were in 2019, before the COVID-19 pandemic upended factory inspections ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results